Global Commercial Pharmaceutical Analytics Market Research Report- Forecast to 2027

Global Commercial Pharmaceutical Analytics Market Research Report- Forecast to 2027

ID: MRFR/HCIT/0332-CRR | October, 2016 | Region: Global | 85 pages | Cooked Research Reports

Global Commercial Pharmaceutical Analytics Market Information, by Types (Prescriptive, Descriptive, Predictive), by Deployment (Cloud, Web Based), by Applications (R&D, Marketing & Sales, Supply Chain Optimizations) - Forecast To 2027


Market Synopsis of Commercial Pharmaceutical Analytics Market:


Market Scenario:


Globally the market for commercial pharmaceutical analytics is increasing rapidly. The major factor that drives the growth of commercial pharmaceutical analytics is growing adoption of new technologies and analytical tools, increasing usage of analytical tools to streamline the business process, growing pharmaceutical industry and others.


Globally the market for commercial pharmaceutical analytics market is expected to grow at the rate of about 20.0% from 2016 to 2027.

Global Commercial Pharmaceutical Analytics Market Share (2015)

Global Commercial Pharmaceutical Analytics Market Share (2015)


Study Objectives of Commercial Pharmaceutical Analytics Market:



  • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the commercial pharmaceutical analytics market  

  • To provide insights about factors affecting the market growth

  • To analyze the commercial pharmaceutical analytics market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by component, by applications and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global market


Intended Audience



  • Healthcare & Life Science Analytics Software Companies

  • Contract Research Organizations (CROs)

  • Research and Development (R&D) Companies

  • Government and Independent Regulatory Authorities

  • Market Research and Consulting Service Providers

  • Academic Medical Institutes and Universities

  • Hospitals & Clinics


Key Finding



  • The global commercial pharmaceutical analytics market and is expected to reach $9,308.4 million by 2027.

  • Descriptive analytics accounted for the largest market share registering 78.34% of market share in 2015

  • Regionally, North America holds the largest market share 48.6% of global commercial pharmaceutical analytics market and is expected to reach $4,299 million by 2027 from $507.4 million in 2015.

  • Asia Pacific market is expected to be the fastest growing market, and expected to grow at a CAGR of 20.8% from 2016 to 2027

  • On the basis of applications, research & development segment holds 40.8% market share


Key Players for Commercial Pharmaceutical Analytics Market:               


Some of the key players in this market are: Allscripts (U.S), Microsoft (U.S), Wipro Limited (U.S), Statistical Analysis System (U.S), Northwest Analytics, INC. (U.S), International Business Machines Corporation (U.S), ORACLE (U.S), Citiustech INC (U.S), Scio Health Analytics (U.S), Take Solutions LTD (U.S), Trinity Pharma Solutions (U.S), Fuzzy Logix INC (U.S), and Cerner Corporation (U.S)


Segments:                                                                                                                                        


Global commercial pharmaceutical analytics market has been segmented on the basis of types which comprises of prescriptive analytics, descriptive analytics, and predictive analytics. On the basis of deployment the market is segmented into cloud based and web based. Furthermore, based on applications the market is segmented into R&D, marketing & sales, supply chain optimizations, internal reporting and others.


Regional Analysis of Commercial Pharmaceutical Analytics Market:                          


Globally, North America is the largest market for commercial pharmaceutical analytics.


Europe is the second-largest market for commercial pharmaceutical analytics. The market is anticipated to reach at $2,613.1 by 2027.


Due to the increasing adoption rate, Asia-pacific is estimated to be the fastest growing region globally, registering 20.8% CAGR during the forecast period.

License
Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency
TABLE OF CONTENTS

2.1 Definition 17

2.2 Scope of Study 18

2.2.1 Research Objective 18

2.2.2 Assumptions & Limitations 18

2.3 Market structure: 19

3.1 Introduction 20

3.2 Primary Research 21

3.3 Secondary research 21

3.4 Market Size Estimation 22

4.1 Drivers 24

4.1.1 Growing Adoption Of New Technologies and Analytical Tools 24

4.1.2 Regulation of R&D Productivity 24

4.1.3 Growing trend of the big data advertisement in Pharma sector. 25

4.1.4 Increasing Usage Of Analytical Tools In Streamlining Business Process 25

4.2 Restraint 26

4.2.1 lack of skilled professionals 26

4.2.2 Conservative Nature of Healthcare Industry. 26

5.1 Porter’s five forces model 27

5.1.1 Introduction 27

5.1.2 Bargaining power of suppliers 28

5.1.3 Bargaining power of Buyers: 28

5.1.4 Intensity of Competitor’s: 28

5.1.5 Threat of new entrants: 29

5.1.6 Threat from Substitutes 29

5.2 Value Chain Analysis 30

5.2.1 Inputs 31

5.2.2 Development Process 31

5.2.3 Output 31

5.2.4 Marketing and Distribution 31

5.2.5 Post Selling Services 31

6.1 Introduction 32

6.1.1 Descriptive Analytics 34

6.1.2 Predictive Analytics 34

6.1.3 Prescriptive Analytics 35

7.1 Introduction 37

7.2 R&D 39

7.2.1 Marketing & Sales 40

7.2.2 Supply Chain Optimization 40

7.2.3 Internal Reporting 41

8.1 On-Premise 45

8.2 Web Based/Cloud Based 46

9.1 Introduction 47

9.2 Software 49

9.3 Services 50

10.1 Introduction 51

10.2 Americas 53

10.2.1 North America 57

10.2.2 Latin America 63

10.3 Europe 65

10.3.1 Western Europe 69

10.3.2 Eastern Europe 81

10.3.3 Asia Pacific 83

10.3.4 Middle East & Africa 97

11.1 Introduction 101

11.1.1 Mergers Acquisitions 102

11.1.2 Collaborations 103

11.1.3 Release/New Product Launches 103

11.1.4 Other (Expansion, Updates, Partnership) 104

12.1 CitiusTech Inc. 106

12.1.1 Company Overview 106

12.1.2 Product/Business Segment Overview 106

12.1.3 Financial Overview 106

12.1.4 Key Development 106

12.2 International Business Machines Corporation 107

12.2.1 Company Overview 107

12.2.2 Product/Business Segment Overview 107

12.2.3 Financial Overview 108

12.2.4 Key Development 109

12.3 Northwest analytics, Inc. 110

12.3.1 Company Overview 110

12.3.2 Product/Business Segment Overview 110

12.3.3 Financial Overview 110

12.3.4 Key Development 110

12.4 ORACLE 111

12.4.1 Company Overview 111

12.4.2 Product/Business Segment Overview 111

12.4.3 Financial Overview 112

12.4.4 Key Development 113

12.5 SCIO HEALTH ANALYTICS 114

12.5.1 Company Overview 114

12.5.2 Product/Business Segment Overview 114

12.5.3 Financial Overview 114

12.5.4 Key Developments 115

12.6 Statistical Analysis System 116

12.6.1 Company Overview 116

12.6.2 Product/Business Segment Overview 116

12.6.3 Financial Overview 117

12.6.4 Key Development 118

12.7 TAKE Solutions Ltd 119

12.7.1 Company Overview 119

12.7.2 Product/Business Segment Overview 119

12.7.3 Financial Overview 120

12.7.4 Key Developments 121

12.8 Tata Consultancy Services Limited 122

12.8.1 Company Overview 122

12.8.2 Product/Business Segment Overview 122

12.8.3 Financial Overview 123

12.8.4 Key Development 124

12.9 TRINITY PHARMA SOLUTIONS 125

12.9.1 Company Overview 125

12.9.2 Product/Business Segment Overview 125

12.9.3 Financial Overview 125

12.9.4 Key Developments 125

12.10 Wipro Limited 126

12.10.1 Company Overview 126

12.10.2 Product/Business Segment Overview 126

12.10.3 Financial Overview 127

12.10.4 Key Development 128

13.1 Key Findings 129

TABLE 1 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 32

TABLE 2 GLOBAL DESCRIPTIVE ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 34

TABLE 3 GLOBAL PREDICTIVE ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 35

TABLE 4 GLOBAL PRESCRIPTIVE ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 36

TABLE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION US$ MILLION 2014-2027 37

TABLE 6 GLOBAL RESEARCH & DEVELOPMENT IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 39

TABLE 7 GLOBAL MARKETING & SALES IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 40

TABLE 8 GLOBAL SUPPLY CHAIN IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 41

TABLE 9 GLOBAL INTERNAL REPORTING IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 42

TABLE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 43

TABLE 11 ON PREMISE MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 45

TABLE 12 WEB BASED/CLOUD BASED MODEL IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 46

TABLE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS US$ MILLION 2014-2027 47

TABLE 14 GLOBAL SOFTWARE COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 49

TABLE 15 GLOBAL SERVICES COMPONENTS IN COMMERCIAL PHARMACEUTICAL ANALYTICS, BY REGION US$ MILLION 2014-2027 50

TABLE 16 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 51

TABLE 17 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 54

TABLE 18 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 55

TABLE 19 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATONS US$ MILLION 2014-2027 55

TABLE 20 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 56

TABLE 21 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 56

TABLE 22 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 57

TABLE 23 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 57

TABLE 24 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 58

TABLE 25 NORTH AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014-2027 58

TABLE 26 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 59

TABLE 27 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 59

TABLE 28 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 60

TABLE 29 US COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 60

TABLE 30 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 61

TABLE 31 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 61

TABLE 32 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 62

TABLE 33 CANADA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 62

TABLE 34 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 63

TABLE 35 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 63

TABLE 36 ATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 64

TABLE 37 LATIN AMERICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 64

TABLE 38 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 66

TABLE 39 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 67

TABLE 40 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 67

TABLE 41 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 68

TABLE 42 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 68

TABLE 43 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 69

TABLE 44 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 69

TABLE 45 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 70

TABLE 46 GERMANY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 70

TABLE 47 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 71

TABLE 48 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 71

TABLE 49 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 72

TABLE 50 FRANCE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 72

TABLE 51 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 73

TABLE 52 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 73

TABLE 53 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 74

TABLE 54 UK COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 74

TABLE 55 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 75

TABLE 56 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 75

TABLE 57 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 76

TABLE 58 ITALY COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 76

TABLE 59 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 77

TABLE 60 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 77

TABLE 61 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 78

TABLE 62 SPAIN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 78

TABLE 63 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 79

TABLE 64 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 79

TABLE 65 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 80

TABLE 66 REST OF WESTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 80

TABLE 67 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014-2027 81

TABLE 68 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014-2027 81

TABLE 69 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014-2027 82

TABLE 70 EASTERN EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014-2027 82

TABLE 71 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014-2027 84

TABLE 72 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 85

TABLE 73 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 85

TABLE 74 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 86

TABLE 75 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 86

TABLE 76 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 87

TABLE 77 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 87

TABLE 78 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 88

TABLE 79 JAPAN COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 88

TABLE 80 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 89

TABLE 81 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 89

TABLE 82 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 90

TABLE 83 CHINA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 90

TABLE 84 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 91

TABLE 85 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 91

TABLE 86 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 92

TABLE 87 INDIA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 92

TABLE 88 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 93

TABLE 89 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 93

TABLE 90 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 94

TABLE 91 SOUTH KOREA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 94

TABLE 92 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 95

TABLE 93 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 95

TABLE 94 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 96

TABLE 95 REST OF ASIA PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENT US$ MILLION 2014 - 2027 96

TABLE 96 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014 - 2027 97

TABLE 97 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2014 - 2027 98

TABLE 98 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY APPLICATION US$ MILLION 2014 - 2027 99

TABLE 99 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2014 - 2027 99

TABLE 100 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY COMPONENTS US$ MILLION 2014 - 2027 100


 

FIGURE 2 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY TYPE, 2016 (%) 14

FIGURE 3 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY APPLICATION, 2016 (%) 14

FIGURE 4 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY DEPLOYMENT, 2016 (%) 15

FIGURE 5 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY COMPONENT, 2016 (%) 15

FIGURE 6 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE, BY REGION, 2016 (%) 16

FIGURE 7 RESEARCH PROCESS 20

FIGURE 8 FORECAST MODEL 23

FIGURE 9 VALUE CHAIN ANALYSIS 30

FIGURE 10 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY TYPE US$ MILLION 2016 & 2027 33

FIGURE 11 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY APPLICATION US$ MILLION 2016 & 2027 38

FIGURE 12 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY DEPLOYMENT US$ MILLION 2016 & 2027 44

FIGURE 13 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS, BY COMPONENTS US$ MILLION 2014 & 2027 48

FIGURE 14 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014 - 2027 52

FIGURE 15 AMERICAS COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 54

FIGURE 16 EUROPE COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 66

FIGURE 17 ASIA-PACIFIC COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION MARKET SHARE 2016 (%) 84

FIGURE 18 MIDDLE EAST & AFRICA COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET, BY REGION US$ MILLION 2014 - 2027 98

FIGURE 19 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET SHARE ANALYSIS 2016 (%) 101

FIGURE 20 GLOBAL COMMERCIAL PHARMACEUTICAL ANALYTICS MARKET COMPETITIVE ANALYSIS 2016 (%) 102

FIGURE 21 RECENT FINANCIALS 108

FIGURE 22 GEOGRAPHICAL REVENUE MIX, 2016 (%) 108

FIGURE 23 SEGMENTAL REVENUE MIX, 2016 (%) 109

FIGURE 24 RECENT FINANCIALS 112

FIGURE 25 GEOGRAPHICAL REVENUE MIX, 2016 (%) 112

FIGURE 26 SEGMENTAL REVENUE MIX, 2016 (%) 113

FIGURE 27 RECENT FINANCIALS 117

FIGURE 28 GEOGRAPHICAL REVENUE MIX, 2016 117

FIGURE 29 SEGMENTAL REVENUE MIX, 2016 118

FIGURE 30 RECENT FINANCIALS (USD MILLION) 120

FIGURE 31 GEOGRAPHIC REVENUE MIX, 2016 (%) 120

FIGURE 32 SEGMENTAL REVENUE MIX, 2016 (%) 121

FIGURE 33 RECENT FINANCIALS 123

FIGURE 34 GEOGRAPHICAL REVENUE MIX, 2016 (%) 123

FIGURE 35 SEGMENTAL MIX, 2016 (%) 124

FIGURE 36 RECENT FINANCIALS 127

FIGURE 37 GEOGRAPHICAL REVENUE MIX, 2016 (%) 127

FIGURE 38 SEGMENTAL REVENUE MIX, 2016 (%) 128